Join
Live feed
·
INSIDERFilingvia Quantisnow
Haemonetics Corporation logo

Director Johnson Lloyd Emerson was granted 2,207 shares, increasing direct ownership by 27% to 10,240 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
HAE· Haemonetics Corporation
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HAE (Haemonetics Corporation) and more on Quantisnow.